NEW YORK (GenomeWeb News) – Molecular diagnostics firm AutoGenomics has filed again for an initial public offering in the US.

In its Form S-1 filed Wednesday with the US Securities and Exchange Commission, the company said that it plans to raise as much as $65 million from the offering. It has not priced its shares or said how many shares it plans to offer.

Leerink Swann, Mizuho Securities, Cantor Fitzgerald, and Stephens are listed as the underwriters in the preliminary prospectus for the IPO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.